Edition:
India

Globus Medical Inc (GMED.N)

GMED.N on New York Stock Exchange

22.62USD
11:23pm IST
Change (% chg)

$0.35 (+1.57%)
Prev Close
$22.27
Open
$22.29
Day's High
$22.96
Day's Low
$22.29
Volume
410,164
Avg. Vol
213,797
52-wk High
$28.98
52-wk Low
$20.48

GMED.N

Chart for GMED.N

About

Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders. It is focused on products to treat patients with spine disorders. Its products fall under categories, which include Innovative Fusion and Disruptive Technologies. The Innovative Fusion... (more)

Overall

Beta: 0.61
Market Cap(Mil.): $2,127.02
Shares Outstanding(Mil.): 95.51
Dividend: --
Yield (%): --

Financials

BRIEF-Globus Medical Q2 non-gaap earnings per share $0.29

* Preliminarily projects 2017 full year sales of $640M including $40M from acquisition

27 Jul 2016

BRIEF-Alphatec Holdings announces sale of international business to Globus Medical

* Alphatec Holdings announces sale of international business to Globus Medical

27 Jul 2016

BRIEF-Globus Medical to buy Alphatec's international business for $80 mln in cash

* Globus Medical announces the acquisition of Alphatec's international business

27 Jul 2016

BRIEF-Acacia Research says Bonutti Skeletal Innovations entered into settlement, license agreement with Globus Medical

* Bonutti Skeletal Innovations Llc entered into a settlement and license agreement with Globus Medical Inc - sec filing

10 Jun 2016

BRIEF-Globus Medical appoints Eric Ian Schwartz as senior vice president, general counsel

* Globus Medical appoints Eric Ian Schwartz as senior vice president and general counsel Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

11 May 2016

BRIEF-Globus Medical reports Q1 earnings per share $0.29

* Q1 earnings per share view $0.28 -- Thomson Reuters I/B/E/S

04 May 2016

Earnings vs. Estimates